News

  • Everything You Need To Know About Doxycycline Hyclate

    Everything You Need To Know About Doxycycline Hyclate

    Doxycycline hyclate, commonly known as doxycycline, is the most frequently used antibacterial drug in veterinary clinical diagnosis. No one can simply judge which one is better between it and fluphenazole. In the veterinary market, o...
    Read more
  • Learn About Pregabalin+Nortriptyline

    Learn About Pregabalin+Nortriptyline

    Pregabalin and Nortriptyline tablets, a combination of two drugs, Pregabalin (anti-convulsant) and Nortriptyline (antidepressant), is used to treat neuropathic pain (a sensation of numbness, tingling and also feels like pins and needles). Pregabalin helps to decrease pai...
    Read more
  • How To Use Thalidomide To Help Develop New Cancer Therapies

    How To Use Thalidomide To Help Develop New Cancer Therapies

    The drug thalidomide was recalled in the 1960s because it caused devastating defects in newborns, but at the same time it was widely used to treat multiple sclerosis and other blood cancers, and can, with its chemical relatives, promote cellular destruction of two specif...
    Read more
  • Everything You Need Know About Pregabalin And Methylcobalamin Capsules

    What are pregabalin and methylcobalamin capsules? Pregabalin and methylcobalamin capsules are a combination of two medicines: pregabalin and methylcobalamin. Pregabalin acts by decreasing the number of pain signals sent by a damaged nerve in the body, and meth...
    Read more
  • ALL ABOUT HYDROCHLOROTHIAZIDE

    ALL ABOUT HYDROCHLOROTHIAZIDE

    Hydrochlorothiazide manufacturers explain everything essential about hydrochlorothiazide to help you know better about it. What is hydrochlorothiazide? Hydrochlorothiazide (HCTZ) is a thiazide diuretic that helps prevent your body from absorbing too much salt, which can ...
    Read more
  • Bayer’s new heart drug Vericiguat is approved in China

    On May 19, 2022, China’s National Medical Products Administration (NMPA) approved the marketing application for Bayer’s Vericiguat (2.5 mg, 5 mg, and 10 mg) under the brand name Verquvo™. This drug is used in adult patients with symptomatic chronic heart failure and red...
    Read more
  • Three major differences between Ruxolitinib and Ruxolitinib cream

    Three major differences between Ruxolitinib and Ruxolitinib cream

    Ruxolitinib is a type of oral targeted therapy called a kinase inhibitor and is mainly used to treat diseases such as graft-versus-host disease, erythroblastosis, and medium-and high-risk myelofibrosis, while Ruxolitinib cream is a topical dermatological agent that is ap...
    Read more
  • Considerations when taking Ruxolitinib for the first time

    Considerations when taking Ruxolitinib for the first time

    Ruxolitinib is a type of targeted cancer drug. It is mainly used to inhibit the activation of the JAK-STAT signaling pathway and lower the signal that suppresses the abnormal enhancement, thus achieving therapeutic effect. It works by...
    Read more
  • Ruxolitinib significantly reduces disease and improves quality of life in patients

    Ruxolitinib significantly reduces disease and improves quality of life in patients

    The treatment strategy for primary myelofibrosis (PMF) is based on risk stratification. Due to the variety of clinical manifestations and issues to be addressed in PMF patients, treatment strategies need to take into acco...
    Read more
  • Ruxolitinib has promising efficacy in myeloproliferative diseases

    Ruxolitinib has promising efficacy in myeloproliferative diseases

    Ruxolitinib, also known as ruxolitinib in China, is one of the "new drugs" that have been widely listed in clinical guidelines for the treatment of hematological diseases in recent years, and has shown promising efficacy in myeloproliferative diseases. The targeted drug ...
    Read more
  • Heart disease needs a new drug – Vericiguat

    Heart disease needs a new drug – Vericiguat

    Heart failure with reduced ejection fraction (HFrEF) is a major type of heart failure, and the China HF Study showed that 42% of heart failures in China are HFrEF, although several standard therapeutic classes of drugs are available for HFrEF and have reduced the risk of...
    Read more
  • Targeted drug for the treatment of myelofibrosis: Ruxolitinib

    Targeted drug for the treatment of myelofibrosis: Ruxolitinib

    Myelofibrosis (MF) is referred to as myelofibrosis. It is also a very rare disease. And the cause of its pathogenesis is not known. Typical clinical manifestations are juvenile red blood cell and juvenile granulocytic anemia with a high number of tear drop red blood cell...
    Read more
123 Next > >> Page 1 / 3